Login / Signup

Targeting CD38 to suppress osteoarthritis development and associated pain after joint injury in mice.

Paulo Gil AlabarseLiang-Yu ChenPatricia OliveiraHuaping QinRu Liu-Bryan
Published in: Arthritis & rheumatology (Hoboken, N.J.) (2022)
CD38 deficiency exerts OA disease modifying effects. Inhibition of CD38 has a potential to be a novel therapeutic approach for OA treatment.
Keyphrases
  • knee osteoarthritis
  • chronic pain
  • nk cells
  • rheumatoid arthritis
  • pain management
  • spinal cord injury
  • high fat diet induced
  • risk assessment
  • human health